Objective: to evaluate the antimicrobial susceptibility profile of Staphylococcus aureus isolates from blood cultures and compare methods for determiningthe minimum inhibitory concentration (MIC) of vancomycin. Methods: an observational study conducted in a tertiary hospital, involving 62 clinical isolates of S. aureus. In addition, the MIC of vancomycin was determined using the Etest®, broth microdilution (BMD), and Vitek® automated system methods. Clinically relevant antimicrobial susceptibility profiles were evaluated, and agreement between methods was analyzed by statistical correlationusing IBM-SPSS® software. The study was approved by the hospital's Research Ethics Committee under registration number 5.557.687/2022. Results: methicillin-sensitive (MSSA) and methicillin-resistant (MRSA) isolates were susceptible to vancomycin, teicoplanin, linezolid, daptomycin, and tigecycline. A better correlation was observed between the vancomycin MIC values obtained by Vitek®2 and BMD compared to Etest®. However, Vitek®2 tended to overestimate MIC compared to BMD. Conclusion: the results indicate the importance of using complementary methods to validate high vancomycin MIC values, contributing to more appropriate therapeutic decisions and the prevention of bacterial resistance.
Introduction: The existence of inconsistencies in the vancomycin minimum inhibitory concentration (MIC) for Staphylococcus aureus obtained by automated methods when compared with the results obtained by methods such as Etest ® and broth microdilution (BMD) shows the necessity of evaluate and compare these results. Materials and Methods: Regarding that, vancomycin MIC, and susceptibility profiles of 62 S. aureus isolates from blood cultures were all determined using the Etest ® , BMD, and Vitek ® 2 methods, these three methods evaluating their susceptibility profiles. Results
and Discussion: Methicillin-sensitive (MSSA) and methicillin-resistant (MRSA) S. aureus strains showed susceptibility to vancomycin, teicoplanin, linezolid, daptomycin and tigecycline. Vitek ® 2 (r = 0.6975, p<0.001) and BMD showed a better correlation between vancomycin MIC compared to Etest ® (r = 0.2563, p<0.00444); however, Vitek ® 2 was overestimated by MIC compared to BMD. Conclusion: Therefore, it is recommended to implement complementary methods to confirm if the high vancomycin MIC results are valid, thereby avoiding inappropriate use of antibiotics and the increase of resistance.